Operating Lease, Right-of-Use Asset of Grace Therapeutics, Inc. from 31 Mar 2020 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Grace Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2020 to 31 Mar 2024.
  • Grace Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2024 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Grace Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $0 -$463,000 -100% 31 Mar 2024 10-K 21 Jun 2024 2024 FY
Q4 2023 $23,000 -$464,000 -95% 31 Dec 2023 10-Q 12 Feb 2024 2024 Q3
Q3 2023 $47,000 -$463,000 -91% 30 Sep 2023 10-Q 13 Nov 2023 2024 Q2
Q2 2023 $71,000 -$748,000 -91% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q1
Q1 2023 $463,000 +$148,000 +47% 31 Mar 2023 10-K 21 Jun 2024 2024 FY
Q4 2022 $487,000 +$465,000 +2114% 31 Dec 2022 10-Q 14 Feb 2023 2022 Q3
Q3 2022 $510,000 +$467,000 +1086% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q2
Q2 2022 $819,000 +$753,000 +1141% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q1
Q1 2022 $315,000 +$229,000 +266% 31 Mar 2022 10-K 23 Jun 2023 2023 FY
Q4 2021 $22,000 -$83,000 -79% 31 Dec 2021 10-Q 14 Feb 2022 2021 Q3
Q3 2021 $43,000 -$76,000 -64% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q2
Q2 2021 $66,000 -$69,000 -51% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q1
Q1 2021 $86,000 -$61,000 -41% 31 Mar 2021 10-K 21 Jun 2022 2022 FY
Q4 2020 $105,000 31 Dec 2020 10-Q 09 Feb 2021 2021 Q3
Q3 2020 $119,000 30 Sep 2020 10-Q 16 Nov 2020 2021 Q2
Q2 2020 $135,000 30 Jun 2020 10-Q 13 Aug 2020 2021 Q1
Q1 2020 $147,000 31 Mar 2020 10-K 22 Jun 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.